Environmental epigenetics in metal exposure

Epigenetics

Volumn 6, Issue 7, 2011, Pages 820-827

  Martinez Zamudio, Ricardo ^a   Ha, Hyo Chol ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chromatin; DNA methylation; Environmental metal; Epigenetic; Gene expression; Histone modification; Metal carcinogenesis

Indexed keywords

APC PROTEIN; ARSENIC; BRAIN DERIVED NEUROTROPHIC FACTOR; CADMIUM; CHROMIUM; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DEATH ASSOCIATED PROTEIN KINASE; DNA; ESTROGEN RECEPTOR ALPHA; HEAT SHOCK PROTEIN 70; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MERCURY; METALLOTHIONEIN I; METALLOTHIONEIN III; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; NICKEL; PROTEIN C FOS; PROTEIN C JUN; PROTEIN P16; PROTEIN P21; PROTEIN P53; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; S ADENOSYLMETHIONINE;

ARTICLE; BINDING AFFINITY; BLADDER CANCER; CANCER RISK; CARCINOGENESIS; COLON POLYPOSIS; DNA METHYLATION; ECOLOGICAL GENETICS; ENVIRONMENTAL EXPOSURE; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; HUMAN; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; LUNG EDEMA; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PANCREAS CANCER; PNEUMONIA;

EID: 79960112920     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.7.16250     Document Type: Article

References (102)

1. Doll R, Morgan LG, Speizer FE. Cancers of the lung and nasal sinuses in nickel workers. Br J Cancer 1970; 24:623-632.
2. Gibb HJ, Lees PS, Pinsky PF, Rooney BC. Lung cancer among workers in chromium chemical production. Am J Ind Med 2000; 38:115-126.
3. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, et al. Cancer risks from arsenic in drinking water. Environ Health Perspect 1992; 97:259-267.
4. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, Liaw J, et al. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol 2007; 166:1381-1391.
5. Biedermann KA, Landolph JR. Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res 1987; 47:3815-3823.
6. Dunnick JK, Benson JM, Hobbs CH, Hahn FF, Cheng YS, Eidson AF. Comparative toxicity of nickel oxide, nickel sulfate hexahydrate and nickel subsulfide after 12 days of inhalation exposure to F344/N rats and B6C3F1 mice. Toxicology 1988; 50:145-156.
7. Biggart NW, Costa M. Assessment of the uptake and mutagenicity of nickel chloride in salmonella tester strains. Mutat Res 1986; 175:209-215.
8. Kerckaert GA, LeBoeuf RA, Isfort RJ. Use of the Syrian hamster embryo cell transformation assay for determining the carcinogenic potential of heavy metal compounds. Fundam Appl Toxicol 1996; 34:67-72.
9. Andrew AS, Klei LR, Barchowsky A. Nickel requires hypoxia-inducible factor-1 alpha, not redox signaling, to induce plasminogen activator inhibitor-1. Am J Physiol Lung Cell Mol Physiol 2001; 281:607-615.
10. Fowler BA, Whittaker MH, Lipsky M, Wang G, Chen XQ. Oxidative stress induced by lead, cadmium and arsenic mixtures: 30-day, 90-day and 180-day drinking water studies in rats: an overview. Biometals 2004; 17:567-568.
11. Thomson S, Hollis A, Hazzalin CA, Mahadevan LC. Distinct stimulus-specific histone modifications at hsp70 chromatin targeted by the transcription factor heat shock factor-1. Mol Cell 2004; 15:585-594.
12. Salnikow K, Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic and chromium. Chem Res Toxicol 2008; 21:28-44.
13. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005; 308:1466-1469.
14. Cropley JE, Suter CM, Beckman KB, Martin DI. Germ-line epigenetic modification of the murine A vy allele by nutritional supplementation. Proc Natl Acad Sci USA 2006; 103:17308-173012.
15. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci USA 2007; 104:13056-13061.
16. Ali AH, Kondo K, Namura T, Senba Y, Takizawa H, Nakagawa Y, et al. Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure. Mol Carcinog 2011; 50:89-99.
17. Ji W, Yang L, Yu L, Yuan J, Hu D, Zhang W, et al. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells. Carcinogenesis 2008; 29:1267-1275.
18. Kondo K, Takahashi Y, Hirose Y, Nagao T, Tsuyuguchi M, Hashimoto M, et al. The reduced expression and aberrant methylation of p16(INK4a) in chromate workers with lung cancer. Lung Cancer 2006; 53:295-302.
19. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007; 8:253-262.
20. Szyf M. The dynamic epigenome and its implications in toxicology. Toxicol Sci 2007; 100:7-23.
21. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128:693-705.
22. Margueron R, Reinberg D. Chromatin structure and the inheritance of epigenetic information. Nat Rev Genet 2010; 11:285-296.
23. Probst AV, Dunleavy E, Almouzni G. Epigenetic inheritance during the cell cycle. Nat Rev Mol Cell Biol 2009; 10:192-206.
24. Talbert PB, Henikoff S. Spreading of silent chromatin: inaction at a distance. Nat Rev Genet 2006; 7:793-803.
25. Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nicolli H, et al. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 1996; 7:117-124.
26. Marshall G, Ferreccio C, Yuan Y, Bates MN, Steinmaus C, Selvin S, et al. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 2007; 99:920-928.
27. Bertolero F, Pozzi G, Sabbioni E, Saffiotti U. Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation. Carcinogenesis 1987; 8:803-808.
28. Lerman SA, Clarkson TW, Gerson RJ. Arsenic uptake and metabolism by liver cells is dependent on arsenic oxidation state. Chem Biol Interact 1983; 45:401-406.
29. Reichard JF, Puga A. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics 2010; 2:87-104.
30. Chanda S, Dasgupta UB, Guhamazumder D, Gupta M, Chaudhuri U, Lahiri S, et al. DNA hypermethylation of promoter of gene p53 and p16 in arsenicexposed people with and without malignancy. Toxicol Sci 2006; 89:431-437.
31. Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, et al. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis 2006; 27:112-116.
32. Chen WT, Hung WC, Kang WY, Huang YC, Chai CY. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase. Histopathology 2007; 51:785-792.
33. Liu J, Benbrahim-Tallaa L, Qian X, Yu L, Xie Y, Boos J, et al. Further studies on aberrant gene expression associated with arsenic-induced malignant transformation in rat liver TRL1215 cells. Toxicol Appl Pharmacol 2006; 216:407-415.
34. INK4a and RASSF1A and induces lung cancer in A/J mice. Toxicol Sci 2006; 91:372-381.
35. Chen H, Li S, Liu J, Diwan BA, Barrett JC, Waalkes MP. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis 2004; 25:1779-1786.
36. Waalkes MP, Liu J, Chen H, Xie Y, Achanzar WE, Zhou YS, et al. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J Natl Cancer Inst 2004; 96:466-474.
37. Zhong CX, Mass MJ. Both hypomethylation and hypermethylation of DNA associated with arsenite exposure in cultures of human cells identified by methylation-sensitive arbitrarily-primed PCR. Toxicol Lett 2001; 122:223-234.
38. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci USA 1997; 94:10907-109012.
39. Reichard JF, Schnekenburger M, Puga A. Long term lowdose arsenic exposure induces loss of DNA methylation. Biochem Biophys Res Commun 2007; 352:188-192.
40. Xie Y, Liu J, Benbrahim-Tallaa L, Ward JM, Logsdon D, Diwan BA, et al. Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology 2007; 236:7-15.
41. Majumdar S, Chanda S, Ganguli B, Mazumder DN, Lahiri S, Dasgupta UB. Arsenic exposure induces genomic hypermethylation. Environ Toxicol 2010; 25:315-318.
42. Gebel TW. Arsenic methylation is a process of detoxification through accelerated excretion. Int J Hyg Environ Health 2002; 205:505-508.
43. Loenen WA. S-adenosylmethionine: jack of all trades and master of everything? Biochem Soc Trans 2006; 34:330-333.
44. Barr FD, Krohmer LJ, Hamilton JW, Sheldon LA. Disruption of histone modification and CARM1 recruitment by arsenic represses transcription at glucocorticoid receptor-regulated promoters. PLoS One 2009; 4:6766.
45. Li J, Gorospe M, Barnes J, Liu Y. Tumor promoter arsenite stimulates histone H3 phosphoacetylation of proto-oncogenes c-fos and c-jun chromatin in human diploid fibroblasts. J Biol Chem 2003; 278:13183-13191.
46. Li J, Gorospe M, Hutter D, Barnes J, Keyse SM, Liu Y. Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylationacetylation. Mol Cell Biol 2001; 21:8213-8224.
47. +3 transformed human urothelial cells. Cancer Cell Int 2011; 11:2.
48. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125:315-326.
49. Zhou X, Li Q, Arita A, Sun H, Costa M. Effects of nickel, chromate and arsenite on histone 3 lysine methylation. Toxicol Appl Pharmacol 2009; 236:78-84.
50. He Z, Ma WY, Liu G, Zhang Y, Bode AM, Dong Z. Arsenite-induced phosphorylation of histone H3 at serine 10 is mediated by Akt1, extracellular signalregulated kinase 2 and p90 ribosomal S6 kinase 2 but not mitogen- and stress-activated protein kinase 1. J Biol Chem 2003; 278:10588-10593.
51. Kannan-Thulasiraman P, Katsoulidis E, Tallman MS, Arthur JS, Platanias LC. Activation of the mitogenand stress-activated kinase 1 by arsenic trioxide. J Biol Chem 2006; 281:22446-22452.
52. Ramirez T, Brocher J, Stopper H, Hock R. Sodium arsenite modulates histone acetylation, histone deacetylase activity and HMGN protein dynamics in human cells. Chromosoma 2008; 117:147-157.
53. Kasprzak KS, Sunderman FW Jr, Salnikow K. Nickel carcinogenesis. Mutat Res 2003; 533:67-97.
54. Morgan LG, Usher V. Health problems associated with nickel refining and use. Ann Occup Hyg 1994; 38:189-198.
55. Fletcher GG, Rossetto FE, Turnbull JD, Nieboer E. Toxicity, uptake and mutagenicity of particulate and soluble nickel compounds. Environ Health Perspect 1994; 102:69-79.
56. Rani AS, Qu DQ, Sidhu MK, Panagakos F, Shah V, Klein KM, et al. Transformation of immortal, non-tumorigenic osteoblast-like human osteosarcoma cells to the tumorigenic phenotype by nickel sulfate. Carcinogenesis 1993; 14:947-953.
57. Trott DA, Cuthbert AP, Overell RW, Russo I, Newbold RF. Mechanisms involved in the immortalization of mammalian cells by ionizing radiation and chemical carcinogens. Carcinogenesis 1995; 16:193-204.
58. Klein CB, Conway K, Wang XW, Bhamra RK, Lin XH, Cohen MD, et al. Senescence of nickel-transformed cells by an X chromosome: possible epigenetic control. Science 1991; 251:796-799.
59. Lee YW, Klein CB, Kargacin B, Salnikow K, Kitahara J, Dowjat K, et al. Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol Cell Biol 1995; 15:2547-2557.
60. Chen H, Ke Q, Kluz T, Yan Y, Costa M. Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing. Mol Cell Biol 2006; 26:3728-3737.
61. Yan Y, Kluz T, Zhang P, Chen HB, Costa M. Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure. Toxicol Appl Pharmacol 2003; 190:272-277.
62. Mohideen K, Muhammad R, Davey CA. Perturbations in nucleosome structure from heavy metal association. Nucleic Acids Res 2010; 38:6301-6311.
63. Borochov N, Ausio J, Eisenberg H. Interaction and conformational changes of chromatin with divalent ions. Nucleic Acids Res 1984; 12:3089-3096.
64. Ellen TP, Kluz T, Harder ME, Xiong J, Costa M. Heterochromatinization as a potential mechanism of nickel-induced carcinogenesis. Biochemistry 2009; 48:4626-4632.
65. Chen H, Kluz T, Zhang R, Costa M. Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS- 2B cells. Carcinogenesis 2010; 31:2136-2144.
66. Cabrita MA, Christofori G. Sprouty proteins, masterminds of receptor tyrosine kinase signaling. Angiogenesis 2008; 11:53-62.
67. Chen H, Giri NC, Zhang R, Yamane K, Zhang Y, Maroney M, et al. Nickel ions inhibit histone demethylase JMJD1A and DNA repair enzyme ABH2 by replacing the ferrous iron in the catalytic centers. J Biol Chem 2010; 285:7374-7383.
68. Klein CB, Costa M. DNA methylation, heterochromatin and epigenetic carcinogens. Mutat Res 1997; 386:163-180.
69. Ke Q, Davidson T, Chen H, Kluz T, Costa M. Alterations of histone modifications and transgene silencing by nickel chloride. Carcinogenesis 2006; 27:1481-1488.
70. Zhang Q, Salnikow K, Kluz T, Chen LC, Su WC, Costa M. Inhibition and reversal of nickel-induced transformation by the histone deacetylase inhibitor trichostatin A. Toxicol Appl Pharmacol 2003; 192:201-211.
71. Broday L, Peng W, Kuo MH, Salnikow K, Zoroddu M, Costa M. Nickel compounds are novel inhibitors of histone H4 acetylation. Cancer Res 2000; 60:238-241.
72. Zoroddu MA, Schinocca L, Kowalik-Jankowska T, Kozlowski H, Salnikow K, Costa M. Molecular mechanisms in nickel carcinogenesis: modeling Ni(II) binding site in histone H4. Environ Health Perspect 2002; 110:719-723.
73. Karaczyn AA, Golebiowski F, Kasprzak KS. Ni(II) affects ubiquitination of core histones H2B and H2A. Exp Cell Res 2006; 312:3252-3259.
74. Ke Q, Ellen TP, Costa M. Nickel compounds induce histone ubiquitination by inhibiting histone deubiquitinating enzyme activity. Toxicol Appl Pharmacol 2008; 228:190-199.
75. Karaczyn AA, Golebiowski F, Kasprzak KS. Truncation, deamidation and oxidation of histone H2B in cells cultured with nickel(II). Chem Res Toxicol 2005; 18:1934-1942.
76. Bal W, Liang R, Lukszo J, Lee SH, Dizdaroglu M, Kasprzak KS. Ni(II) specifically cleaves the C-terminal tail of the major variant of histone H2A and forms an oxidative damage-mediating complex with the cleavedoff octapeptide. Chem Res Toxicol 2000; 13:616-624.
77. Karaczyn AA, Bal W, North SL, Bare RM, Hoang VM, Fisher RJ, et al. The octapeptidic end of the C-terminal tail of histone H2A is cleaved off in cells exposed to carcinogenic nickel(II). Chem Res Toxicol 2003; 16:1555-1559.
78. Karavelas T, Mylonas M, Malandrinos G, Plakatouras JC, Hadjiliadis N, Mlynarz P, et al. Coordination properties of Cu(II) and Ni(II) ions towards the C-terminal peptide fragment-ELAKHA-of histone H2B. J Inorg Biochem 2005; 99:606-615.
79. Gibb HJ, Lees PS, Pinsky PF, Rooney BC. Clinical findings of irritation among chromium chemical production workers. Am J Ind Med 2000; 38:127-131.
80. Shi H, Hudson LG, Liu KJ. Oxidative stress and apoptosis in metal ion-induced carcinogenesis. Free Radic Biol Med 2004; 37:582-593.
81. Zhitkovich A. Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI). Chem Res Toxicol 2005; 18:3-11.
82. Takahashi Y, Kondo K, Hirose T, Nakagawa H, Tsuyuguchi M, Hashimoto M, et al. Microsatellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate-exposed workers. Mol Carcinog 2005; 42:150-158.
83. Klein CB, Su L, Bowser D, Leszczynska J. Chromateinduced epimutations in mammalian cells. Environ Health Perspect 2002; 110:739-743.
84. Sun H, Zhou X, Chen H, Li Q, Costa M. Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium. Toxicol Appl Pharmacol 2009; 237:258-266.
85. Schnekenburger M, Talaska G, Puga A. Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histoneremodeling marks critical for transcriptional activation. Mol Cell Biol 2007; 27:7089-7101.
86. Arita A, Costa M. Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics 2009; 1:222-228.
87. Waalkes MP. Cadmium carcinogenesis in review. J Inorg Biochem 2000; 79:241-244.
88. Waalkes MP, Anver MR, Diwan BA. Chronic toxic and carcinogenic effects of oral cadmium in the Noble (NBL/Cr) rat: induction of neoplastic and proliferative lesions of the adrenal, kidney, prostate and testes. J Toxicol Environ Health A 1999; 58:199-214.
89. Waalkes MP. Cadmium carcinogenesis. Mutat Res 2003; 533:107-120.
90. Benbrahim-Tallaa L, Waterland RA, Dill AL, Webber MM, Waalkes MP. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase. Environ Health Perspect 2007; 115:1454-1459.
91. Takiguchi M, Achanzar WE, Qu W, Li G, Waalkes MP. Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp Cell Res 2003; 286:355-365.
92. Doi T, Puri P, McCann A, Bannigan J, Thompson J. Epigenetic effect of cadmium on global de novo DNA hypomethylation in the cadmium-induced ventral body wall defect (VBWD) in the chick model. Toxicol Sci 2011; 120:475-480.
93. Huang D, Zhang Y, Qi Y, Chen C, Ji W. Global DNAhypomethylation, rather than reactive oxygen species (ROS), a potential facilitator of cadmium-stimulated K562 cell proliferation. Toxicol Lett 2008; 179:43-47.
94. Jiang G, Xu L, Song S, Zhu C, Wu Q, Zhang L, et al. Effects of long-term low-dose cadmium exposure on genomic DNA methylation in human embryo lung fibroblast cells. Toxicology 2008; 244:49-55.
95. Johansson C, Castoldi AF, Onishchenko N, Manzo L, Vahter M, Ceccatelli S. Neurobehavioural and molecular changes induced by methylmercury exposure during development. Neurotox Res 2007; 11:241-260.
96. Vahter M, Akesson A, Lind B, Bjors U, Schutz A, Berglund M. Longitudinal study of methylmercury and inorganic mercury in blood and urine of pregnant and lactating women, as well as in umbilical cord blood. Environ Res 2000; 84:186-194.
97. Parran DK, Barone S Jr, Mundy WR. Methylmercury decreases NGF-induced TrkA autophosphorylation and neurite outgrowth in PC12 cells. Brain Res Dev Brain Res 2003; 141:71-81.
98. Tamm C, Duckworth J, Hermanson O, Ceccatelli S. High susceptibility of neural stem cells to methylmercury toxicity: effects on cell survival and neuronal differentiation. J Neurochem 2006; 97:69-78.
99. Larkfors L, Oskarsson A, Sundberg J, Ebendal T. Methylmercury induced alterations in the nerve growth factor level in the developing brain. Brain Res Dev Brain Res 1991; 62:287-291.
100. Onishchenko N, Karpova N, Sabri F, Castren E, Ceccatelli S. Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury. J Neurochem 2008; 106:1378-1387.
101. Costa M. DNA-protein complexes induced by chromate and other carcinogens. Environ Health Perspect 1991; 92:45-52.
102. Misra RR, Smith GT, Waalkes MP. Evaluation of the direct genotoxic potential of cadmium in four different rodent cell lines. Toxicology 1998; 126:103-114.